Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2016 / Cilt: 62 - Sayı: 4

Investigation of neuroprotective effects of topiramate as an antiepileptic agent in experimental spinal cord injury model

Bir antiepileptik ajan olan topiramatın nöroprotektif etkilerinin deneysel spinal kord travma modelinde incelenmesi

Pages
355–364
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We observed minimal edema and near-normal gray and white matter findings in the posttraumatic sections of group 4 and group 5 in the histopathological examination.Conclusion: We think that topiramate has a neuroprotective effect that can be used in the treatment of acute spinal cord injury in rats, based on biochemical markers, histological examination and motor function assessment data, but there is the need for further studies on this matter

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to research neuroprotective effects of topiramate that has antioxidant effects in spinal cord injury in rats.Materials and methods: We performed the study with 40 male Wistar albino rats.
📊
Key Findings & Data:Group 1 (n=8); laminectomy was performed, trauma was not created, treatment was not given.
💡
Conclusion & Impact:We observed minimal edema and near-normal gray and white matter findings in the posttraumatic sections of group 4 and group 5 in the histopathological examination.Conclusion: We think that topiramate has a neuroprotective effect that can be used in the treatment of acute spinal cord injury in rats, based on biochemical markers, histological examination and motor function assessment data, but there is the need for further studies on this matter
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to research neuroprotective effects of topiramate that has antioxidant effects in spinal cord injury in rats.Materials and methods: We performed the study with 40 male Wistar albino rats. We divided the rats in five groups in terms of performed procedures. Group 1 (n=8); laminectomy was performed, trauma was not created, treatment was not given. Group 2 (n=8); laminectomy was performed, trauma was created, treatment was not given. Group 3 (n=8); laminectomy was performed, trauma created, saline (30 mg/kg) was given. Group 4 (no=8); laminectomy was performed, trauma was created, methylprednisolone (30 mg/kg) was given. Group 5 (n=8); laminectomy was performed, trauma was created, topiramate (30 mg/kg) was given. The trauma was created through clipping the spinal cord by Yaşargil aneurysm clip (Aesculap FE 721 K). Motor functions were evaluated by using the inclined plane test on the first day after injury. Malondialdehyde (MDA), catalase (CAT), glutathione peroxidase (GPx) and superoxide dismutase (SOD) levels in the spinal cord tissue samples taken, were measured by ELISA method.Results: We found statistically significant difference for high levels of MDA between group 1 and groups 4 and 5 (p=0.013). There was no statistically significant difference in terms of SOD level between group 4 and group 5 (p=0.80). There was no statistically significant difference for GPx levels between group 4 and group 5 (p=0.51). There was no statistically significant difference for CAT levels between group 4 and group 5 (p=0.38). Results of group 4 and group 5 had the best value among the treatment groups in motor activity examination by inclined plane test. We observed minimal edema and near-normal gray and white matter findings in the posttraumatic sections of group 4 and group 5 in the histopathological examination.Conclusion: We think that topiramate has a neuroprotective effect that can be used in the treatment of acute spinal cord injury in rats, based on biochemical markers, histological examination and motor function assessment data, but there is the need for further studies on this matter

Özet

Amaç: Bu çalışmada spinal kord yaralanmasında antioksidan etkisi olan topiramatın sıçanlardaki nöroprotektif etkisi araştırıldı.Gereç ve yöntemler: Çalışma 40 adet Wistar albino cinsi erkek sıçan ile yapıldı. Sıçanlar yapılan işlemlere göre beş gruba ayrıldı. Grup 1 (n=8); laminektomi yapıldı, travma oluşturulmadı, tedavi verilmedi. Grup 2 (n=8); laminektomi yapıldı, travma oluşturuldu, tedavi verilmedi. Grup 3 (n=8); laminektomi yapıldı, travma oluşturuldu, salin (30 mg/kg) verildi. Grup 4 (n=8); laminektomi yapıldı, travma oluşturuldu, metilprednizolon (30 mg/kg) verildi. Grup 5 (n=8); laminektomi yapıldı, travma oluşturuldu, topiramat (30 mg/kg) verildi. Travma spinal kordun Yaşargil anevrizma klipsiyle (Aesculap FE 721 K) kliplenmesi ile oluşturuldu. Motor fonksiyonlar travma sonrası birinci günde eğik düzlem testi kullanılarak değerlendirildi. Alınan spinal kord doku örneklerinde malondialdehit (MDA), katalaz (CAT), glutatyon peroksidaz (GPx) ve süperoksit dismutaz (SOD) düzeyleri ELISA yöntemi ile ölçüldü.Bulgular: MDA yüksekliği açısından grup 1 ile grup 4 ve grup 5 arasında istatistiksel olarak anlamlı fark saptandı (p=0.013). Grup 4 ve grup 5 arasında SOD düzeyi açısından istatistiksel fark görülmedi (p=0.80). Grup 4 ve grup 5 arasında GPx düzeyi açısından istatistiksel olarak anlamlı fark saptanmadı (p=0.51). Grup 4 ve grup 5 arasında CAT düzeyi açısından istatistiksel fark görülmedi (p=0.38). Eğik düzlem testinde motor aktivite açısından grup 4 ve grup 5'in sonuçları tedavi grupları arasında en iyi değere sahipti. Histopatolojik incelemede grup 4 ve grup 5'te travma sonrası kesitlerde minimal ödem, normale yakın gri ve beyaz cevher bulguları izlendi.Sonuç: Sıçanlarda oluşturulan akut spinal kord travma modelinde biyokimyasal belirteçler, histolojik inceleme, motor fonksiyon değerlendirme verilerine dayanılarak, topiramatın nöroprotektif etkili olduğu, omurilik travmalarının akut tedavisinde kullanılabileceği, ancak bu konuda daha çok çalışmaya ihtiyaç olduğu görüşündeyiz

🔖

Cite This Article

DEMİREL, D., ŞİMŞEK, H., DİNÇ, C., İPÇİOĞLU, O., EROĞLU, A., TOPUZ, A. K. (2022). Investigation of neuroprotective effects of topiramate as an antiepileptic agent in experimental spinal cord injury model. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 62 - Sayı: 4, 355–364. https://ajindex.com/articles/628660

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Fehlings MG, Sekhon LH, Tator C. The role and timing of decompression in acute spinal cord injury: what do we know? What should we do? Spine (Phila Pa 1976) 2001
  2. 2 Hardman JM, Davis RL, Robertson DM, editors. Textbook of Neuropathology. Baltimore: William & Wilkins
  3. p. 1212-15. 3. Karacan I, Koyuncu H, Pekel O, Sümbüloglu G, Kirnap M, Dursun H, et al. Traumatic spinal cord injuries in Turkey: a nation-wide epidemiological study. Spinal Cord 2000
  4. Zileli M. Omurilik Yaralanmasının Farmakolojik Tedavisi. In: Zileli M, Ozer F, editörler. Omurilik ve Omurga Cerrahisi. 1. Baskı. İzmir: Saray Medikal Yayıncılık
  5. s. 466-78. 5. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990
  6. Agrawal SK, Nashmi R, Fehlings MG. Role of L- and N-type calcium channels in the pathophysiology of traumatic spinal cord white matter injury. Neuroscience 2000
  7. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, et al. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 2001
  8. Cayli SR, Kocak A, Yilmaz U, Tekiner A, Erbil M, Ozturk C, et al. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury. Eur Spine J 2004
  9. Fee DB, Swartz KR, Joy KM, Roberts KN, Scheff NN, Scheff SW. Effects of progesterone on experimental spinal cord injury. Brain Res 2007
  10. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997
  11. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990
  12. Pappalardo A, Liberto A, Patti F, Reggio A. Neuroprotective effects of topiramate. Clin Ter 2004
  13. [Abstract] 13. Lee SR, Kim SP, Kim JE. Protective effect